Clinical Trial Update: How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether reduced dosing of latanoprost and dorzolamide-timolol affects intraocular pressure in glaucoma, and the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Drugs mentioned

• Dorzolamide-timolol (Dorzolamide-timolol)
• Latanoprost (Latanoprost)

Snippet

Sponsor: CT Glaucoma Associates | Conditions: Glaucoma, Open-Angle, Glaucoma; Drugs | Phase 4 | Status: TERMINATED